You are here:

Home
NICE Guidance
Conditions and diseases
Skin conditions
Psoriasis

Infliximab for the treatment of adults with psoriasis

Technology appraisal guidance
Reference number: TA134
Published: 23 January 2008

Guidance
Tools and resources
Information for the public
History

Commentators

Wyeth Pharmaceuticals
Merck Serono
Cochrane Skin Group

This page was last updated: 30 March 2010